Invention Grant
- Patent Title: Methods for lowering blood sugar with a metformin pharmaceutical composition
-
Application No.: US16440787Application Date: 2019-06-13
-
Publication No.: US11501857B2Publication Date: 2022-11-15
- Inventor: Robert Peter Prybolsky , Judy Firor
- Applicant: AstraZeneca UK Limited
- Applicant Address: GB Cambridge
- Assignee: AstraZeneca UK Limited
- Current Assignee: AstraZeneca UK Limited
- Current Assignee Address: GB Cambridge
- Agency: Morgan, Lewis & Bockius LLP
- Agent Brett A. Lovejoy; Andrew J. Antczak
- Main IPC: G16H10/40
- IPC: G16H10/40 ; G16H50/30 ; G16H20/10

Abstract:
A method is provided for lowering blood sugar in a subject in need thereof by administering a biguanide anti-hyperglycemic pharmaceutical composition to a subject qualified for over-the-counter access to the biguanide anti-hyperglycemic pharmaceutical composition. In some embodiments, the biguanide anti-hyperglycemic pharmaceutical composition includes N,N-dimethylimidodicarbonimidic diamide, or a pharmaceutically acceptable salt thereof. In some embodiments, the biguanide anti-hyperglycemic pharmaceutical composition includes metformin hydrochloride.
Public/Granted literature
- US20190385712A1 METHODS FOR LOWERING BLOOD SUGAR WITH A METFORMIN PHARMACEUTICAL COMPOSITION Public/Granted day:2019-12-19
Information query